CRISPR Therapeutics AG (CRSP) Return on Capital Employed Growth (1y) (2017 - 2026)
CRISPR Therapeutics AG (CRSP) Return on Capital Employed Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 2,400.00 |
| 10 | CRISPR Therapeutics AG | 4.53 Bn | 4.53 Bn | - | -464.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -464.00 |
| Dec 31, 2025 | -997.00 |
| Sep 30, 2025 | -1,340.00 |
| Jun 30, 2025 | -1,203.00 |
| Mar 31, 2025 | -928.00 |
| Dec 31, 2024 | -1,073.00 |
| Sep 30, 2024 | 581.00 |
| Jun 30, 2024 | 700.00 |
| Mar 31, 2024 | 1,331.00 |
| Dec 31, 2023 | 2,006.00 |
| Sep 30, 2023 | 958.00 |
| Jun 30, 2023 | 356.00 |
| Mar 31, 2023 | -3,895.00 |
| Dec 31, 2022 | -4,493.00 |
| Sep 30, 2022 | -4,533.00 |
| Jun 30, 2022 | -4,548.00 |
| Mar 31, 2022 | 3,401.00 |
| Dec 31, 2021 | 3,669.00 |
| Sep 30, 2021 | 3,483.00 |
| Jun 30, 2021 | 1,967.00 |